SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $144,000 | -16.8% | 19,153 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $173,000 | -19.5% | 19,153 | +6.7% | 0.00% | 0.0% |
Q2 2021 | $215,000 | +76.2% | 17,953 | -5.8% | 0.00% | 0.0% |
Q1 2020 | $122,000 | -71.4% | 19,050 | -62.5% | 0.00% | -50.0% |
Q4 2019 | $426,000 | -4.3% | 50,850 | +3.5% | 0.00% | -20.0% |
Q3 2019 | $445,000 | +8.3% | 49,150 | +28.8% | 0.01% | +25.0% |
Q2 2019 | $411,000 | – | 38,149 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |